Thomas Tuschl

E849217

Thomas Tuschl is a German biochemist and pioneering RNA interference researcher whose work helped lay the scientific foundation for RNA-based therapeutics.

All labels observed (1)

Label Occurrences
Thomas Tuschl canonical 3

How this entity was disambiguated

Statements (45)

Predicate Object
instanceOf RNA interference researcher
biochemist
human
university teacher
awardReceived Ernst Jung Prize for Medicine
Louis-Jeantet Prize for Medicine
Massry Prize
Meyenburg Cancer Research Award
linked to: Meyenburg Prize

Meyenburg Prize
countryOfCitizenship Germany
educatedAt Max Planck Institute for Experimental Medicine
University of Regensburg
employer Rockefeller University
familyName Tuschl
fieldOfWork RNA biology
RNA interference
RNA therapeutics
biochemistry
gene silencing
molecular biology
givenName Thomas
hasAcademicAdvisor Ernst-Ludwig Winnacker
Fritz Eckstein
hasResearchInterest RNA processing
microRNAs
post-transcriptional gene regulation
small interfering RNAs
influenced development of RNAi-based drugs
influencedBy Andrew Fire
Craig Mello
linked to: Craig C. Mello
knownFor demonstrating that synthetic siRNAs can induce RNAi in mammalian cells
design rules for effective siRNAs
patents on RNA interference technologies
languageSpoken English
German
memberOf Howard Hughes Medical Institute
Max Planck Society (as researcher/alumnus)
linked to: Max Planck Society
name Thomas Tuschl
nationality German
notableFor contributions to RNA-based therapeutics
development of small interfering RNA (siRNA) technology
pioneering work on RNA interference in mammalian cells
positionHeld professor at Rockefeller University
sexOrGender male
workLocation New York City

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Alnylam Pharmaceuticals foundedBy Thomas Tuschl
Alnylam Pharmaceuticals, Inc. foundedBy Thomas Tuschl
subject linked to: ALNY
Thomas Tuschl name Thomas Tuschl